Published in Nephrol Dial Transplant on January 01, 1992
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
Interferon-alpha-induced acute renal allograft rejection. Transplantation (1995) 0.95
Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design. Front Immunol (2014) 0.87
Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation. Can J Gastroenterol (2006) 0.75
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet (2000) 4.67
Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science (2002) 3.46
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology (2005) 3.42
Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ (1991) 3.17
Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations. Transplantation (1992) 2.69
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet (1984) 2.65
The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med (1993) 2.50
Unilateral leptomeningeal enhancement after carotid stent insertion detected by magnetic resonance imaging. Stroke (2000) 2.33
Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23
The dynamics of human cytomegalovirus replication in vivo. J Exp Med (1999) 2.19
Neuroimaging for non-accidental head injury in childhood: a proposed protocol. Clin Radiol (2003) 2.15
Comparison of Doppler ultrasound, magnetic resonance angiographic techniques and catheter angiography in evaluation of carotid stenosis. Clin Radiol (2000) 2.11
Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet (2004) 2.09
Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun (1981) 2.08
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease. Lancet (1994) 2.05
Long-term outcome of peritoneal dialysis in infants. J Pediatr (2000) 2.01
On-line acquisition of the output of AutoAnalyzers. J Clin Pathol (1969) 1.96
Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition? Lancet (1987) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol (1989) 1.84
Comparison of ultrasound and magnetic resonance imaging in 100 singleton pregnancies with suspected brain abnormalities. BJOG (2004) 1.83
Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet (1997) 1.83
Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J Infect Dis (1997) 1.77
HHV-6 in AIDS. Lancet (1994) 1.76
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
Investigating the functional anatomy of empathy and forgiveness. Neuroreport (2001) 1.69
Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS (1997) 1.68
Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol. J Clin Invest (2001) 1.68
Noise levels in a clinical chemistry laboratory. J Clin Pathol (1970) 1.68
Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis (1983) 1.67
Use of monoclonal antibodies for the diagnosis of cytomegalovirus infection by the detection of early antigen fluorescent foci (DEAFF) in cell culture. J Med Virol (1987) 1.65
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol (2002) 1.63
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Serum levels of ATP: creatine phosphotransferase (creatine kinase). The normal range and effect of muscular activity. Clin Chim Acta (1966) 1.59
Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 1.59
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant (1998) 1.58
Spinal-cord involvement in diabetic peripheral neuropathy. Lancet (2001) 1.57
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS (1992) 1.56
Involvement of the anterior lobe of the cerebellar vermis in perinatal profound hypoxia. AJNR Am J Neuroradiol (2007) 1.55
The effects of dehydration on brain volume -- preliminary results. Int J Sports Med (2005) 1.55
HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature (1990) 1.52
Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. J Clin Pathol (1982) 1.47
Serum enzymes in diseases of the thyroid gland. J Clin Pathol (1965) 1.46
Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation (1995) 1.45
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Acute pancreatitis and diabetic ketoacidosis in accidental hypothermia and hypothermic myxoedema. Br Med J (1973) 1.45
Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain (2000) 1.45
Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect Immun (1982) 1.44
Beta 2 microglobulin enhances the infectivity of cytomegalovirus and when bound to the virus enables class I HLA molecules to be used as a virus receptor. J Gen Virol (1987) 1.44
Viral burden in HIV infection. Nature (1994) 1.43
Serum-enzymes in relation to electrocardiographic changes in accidental hypothermia. Lancet (1968) 1.43
Progress towards interrupting intrauterine transmission of cytomegalovirus? Rev Med Virol (2005) 1.42
Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet (1988) 1.41
Choice of cross size in stereology--a cautionary note. Neuroradiology (2003) 1.39
Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant (1989) 1.39
Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant (1990) 1.38
A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol (1984) 1.38
Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol (1992) 1.38
The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Commun (1998) 1.37
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35
An improved radioimmunoassay method for the detection of IgG antibodies against cytomegalovirus. J Virol Methods (1986) 1.35
Simplified quantification of urinary protein excretion in children. Clin Nephrol (1988) 1.35
Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. J Gen Virol (1992) 1.35
Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J Gen Virol (1991) 1.34
Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis (1999) 1.34
Two clinical isolates and the Toledo strain of cytomegalovirus contain endothelial cell tropic variants that are not present in the AD169, Towne, or Davis strains. J Med Virol (1999) 1.33
Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells. J Gen Virol (1987) 1.32
A prospective study of primary cytomegalovirus infection in pregnant women. Br J Obstet Gynaecol (1980) 1.31
Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ (1996) 1.31
Intracranial MR venography in children: normal anatomy and variations. AJNR Am J Neuroradiol (2004) 1.31
Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol (1988) 1.30
A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies. J Clin Pathol (1978) 1.30
Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci U S A (2000) 1.30
Clinical chemistry usage in Britain and Canada. N Engl J Med (1980) 1.30
Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis (1982) 1.30
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
MR imaging and spectroscopy in Lhermitte-Duclos disease. Neuroradiology (2004) 1.29
Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol (1989) 1.28
Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study. Lancet (1980) 1.27
Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology (2004) 1.26
Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol (1995) 1.26
Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology (1997) 1.25
Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am J Transplant (2008) 1.24